hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance

Barrett's esophagus (BE) is the only well-known precursor lesion of esophageal adenocarcinoma (EA). The exact estimates of the annual progression rate from BE to EA vary from 0.07% to 3.6%. The identification of BE patients at higher risk to progress to EA is hence mandatory, although difficult...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Lastraioli, Elena, Lottini, Tiziano, Iorio, Jessica, Freschi, Giancarlo, Fazi, Marilena, Duranti, Claudia, Carraresi, Laura, Messerini, Luca, Taddei, Antonio, Ringressi, Maria Novella, Salemme, Marianna, Villanacci, Vincenzo, Vindigni, Carla, Tomezzoli, Anna, Mendola, Roberta La, Bencivenga, Maria, Compagnoni, Bruno, Chiudinelli, Mariella, Saragoni, Luca, Manzi, Ilaria, Manzoni, Giovanni De, Bechi, Paolo, Boni, Luca, Arcangeli, Annarosa
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312329/
https://ncbi.nlm.nih.gov/pubmed/27517748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11149
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller